BBInternational

BBI Solutions is a leading developer and manufacturer of raw materials and finished test platforms for the in-vitro diagnostics (IVD) market. With over 50 years of experience, BBI serves the global diagnostics industry, offering a comprehensive portfolio of products and services.

Product Portfolio:

• Reagents: BBI provides a wide range of immuno-diagnostic reagents, including human antigens, antibodies, enzymes, gold nanoparticles and conjugates, as well as serum and plasma products.
• Services: The company offers custom antibody development, lateral flow assay development, and manufacturing services, supporting clients from concept through to commercialization.

History and Growth:

Founded in 1986 by John Chandler at Cardiff University, BBI initially developed and manufactured gold nanoparticles for the electron microscopy industry. Over the years, the company expanded its product range and services through strategic acquisitions and investments, including the acquisition of Novarum DX Ltd in 2016 and DIARECT AG in 2020.

Global Presence:

Headquartered in Crumlin, Wales, United Kingdom, BBI Solutions operates internationally, serving clients across various sectors, including diagnostics, healthcare, research, defense, and food industries.